Limits...
The worldwide epidemiology of acute rheumatic fever and rheumatic heart disease.

Seckeler MD, Hoke TR - Clin Epidemiol (2011)

Bottom Line: Acute rheumatic fever (ARF) and rheumatic heart disease (RHD) are significant public health concerns around the world.Despite decreasing incidence, there is still a significant disease burden, especially in developing nations.This review provides background on the history of ARF, its pathology and treatment, and the current reported worldwide incidence of ARF and prevalence of RHD.

View Article: PubMed Central - PubMed

Affiliation: Department of Pediatrics, Division of Cardiology, University of Virginia, Charlottesville, VA, USA.

ABSTRACT
Acute rheumatic fever (ARF) and rheumatic heart disease (RHD) are significant public health concerns around the world. Despite decreasing incidence, there is still a significant disease burden, especially in developing nations. This review provides background on the history of ARF, its pathology and treatment, and the current reported worldwide incidence of ARF and prevalence of RHD.

No MeSH data available.


Related in: MedlinePlus

Number of reported occurrences of each streptococcal M-type in A) developing nations, B) developed nations, and C) both combined.Note: *denotes M-types contained in 26-valent GABHS vaccine.Abbreviation: NT, nontypeable.
© Copyright Policy
Related In: Results  -  Collection


getmorefigures.php?uid=PMC3046187&req=5

f10-clep-3-067: Number of reported occurrences of each streptococcal M-type in A) developing nations, B) developed nations, and C) both combined.Note: *denotes M-types contained in 26-valent GABHS vaccine.Abbreviation: NT, nontypeable.

Mentions: The reported M-types are presented in Figure 10, showing M-types from developing nations (Figure 10a), developed nations (Figure 10b), and both combined (Figure 10c). For comparison, in Figure 10 the 26 M-types present in the GABHS vaccine currently being tested are noted by an asterisk.69,241


The worldwide epidemiology of acute rheumatic fever and rheumatic heart disease.

Seckeler MD, Hoke TR - Clin Epidemiol (2011)

Number of reported occurrences of each streptococcal M-type in A) developing nations, B) developed nations, and C) both combined.Note: *denotes M-types contained in 26-valent GABHS vaccine.Abbreviation: NT, nontypeable.
© Copyright Policy
Related In: Results  -  Collection

Show All Figures
getmorefigures.php?uid=PMC3046187&req=5

f10-clep-3-067: Number of reported occurrences of each streptococcal M-type in A) developing nations, B) developed nations, and C) both combined.Note: *denotes M-types contained in 26-valent GABHS vaccine.Abbreviation: NT, nontypeable.
Mentions: The reported M-types are presented in Figure 10, showing M-types from developing nations (Figure 10a), developed nations (Figure 10b), and both combined (Figure 10c). For comparison, in Figure 10 the 26 M-types present in the GABHS vaccine currently being tested are noted by an asterisk.69,241

Bottom Line: Acute rheumatic fever (ARF) and rheumatic heart disease (RHD) are significant public health concerns around the world.Despite decreasing incidence, there is still a significant disease burden, especially in developing nations.This review provides background on the history of ARF, its pathology and treatment, and the current reported worldwide incidence of ARF and prevalence of RHD.

View Article: PubMed Central - PubMed

Affiliation: Department of Pediatrics, Division of Cardiology, University of Virginia, Charlottesville, VA, USA.

ABSTRACT
Acute rheumatic fever (ARF) and rheumatic heart disease (RHD) are significant public health concerns around the world. Despite decreasing incidence, there is still a significant disease burden, especially in developing nations. This review provides background on the history of ARF, its pathology and treatment, and the current reported worldwide incidence of ARF and prevalence of RHD.

No MeSH data available.


Related in: MedlinePlus